{
    "2020-12-17": [
        [
            {
                "time": "2020-12-17",
                "original_text": "恒瑞医药事件点评：PD-1适应症再扩展 助力公司脱颖而出",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "PD-1",
                        "适应症",
                        "扩展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-17",
                "original_text": "连续两天暴跌20%，祸起“1元定增”？荣科科技澄清：系误读 连续下跌",
                "features": {
                    "keywords": [
                        "荣科科技",
                        "暴跌",
                        "1元定增",
                        "误读"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-17",
                "original_text": "医保谈判第三日场外：投行券商人士急探消息，PD-1市场几大厂商齐聚",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "PD-1",
                        "厂商",
                        "齐聚"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-17",
                "original_text": "白马股狂飙！白酒第四轮牛市一个茅台碾压整个军工药茅恒瑞新增400亿市值？外资公募共享年末红利！",
                "features": {
                    "keywords": [
                        "白马股",
                        "白酒",
                        "恒瑞",
                        "外资",
                        "公募"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-17",
                "original_text": "恒瑞医药股价创历史新高业内：2021年医药股将迎估值切换硬核资产高估值或成新常态",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "股价",
                        "历史新高",
                        "估值切换"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}